Acadia Pharmaceuticals Inc., of San Diego, appointed Mary Ann Gray to its board.

Adaltis Inc., of Montreal, appointed Jacques Deforges vice president finance and chief financial officer.

Adolor Corp., of Exton, Pa., appointed Roger Graham senior vice president, sales and marketing.

Advanced Cell Technology Inc., of Worcester, Mass., appointed Jonathan Atzen senior vice president and general counsel.

Aerogen Inc., of Mountain View, Calif., appointed Richard Daly a director.

Ambrx Inc., of San Diego, appointed August Watanabe to its board.

American Pharmaceutical Partners Inc., of Schaumburg, Ill., appointed Mark Van Ausdal vice president and general counsel.

Transport Pharmaceuticals Inc., of Framingham, Mass., appointed Tom Amick to its board, Henry Piel director of quality assurance, Meri Bloom director of regulatory affairs, Ed Doherty director of manufacturing, Georgina Weber associate director of clinical operations, and it promoted Phil Friden to vice president of research and development.

VaxGen Inc., of Brisbane, Calif., appointed Paul Laland vice president, corporate and financial communications.

WeissComm Partners, of New York, appointed Terri Clevenger executive vice president.